CAPD 2 Balance Peritoneal Dialysis Solution
Sodium Chloride 11.279g · Calcium Chloride Hydrate 0.5145g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
MFDS item code 200009104 · Notified 2000.07.21 · Insurance code 664300180,664300190,664300200,664300210
Peritoneal dialysis treatment in patients with acute or chronic renal failure
This medication is used for peritoneal dialysis treatment in patients with acute and chronic kidney failure.
1. The attending physician should adjust the treatment method, number of procedures, exchange volume, dialysis time, and duration according to the patient’s condition. 2. Use as a solution for intraperitoneal administration for dialysis treatment. 3. The dose varies according to body size, and the frequency of solution exchanges should be adjusted appropriately based on biochemical parameters and fluid volume control. In adults, the usual procedure is to instill 1.5~2.5L into the peritoneal cavity per exchange, allow it to dwell for 4~8 hours, and then drain it; this process is performed 3~5 times daily. 4. If a machine is used intermittently or continuously for peritoneal dialysis, it is preferable to use a bag with a volume greater than the machine’s exchange volume. 5. The glucose concentration should be selected according to the patient’s ultrafiltration needs and kept as low as possible
This medication is a dialysis solution used for peritoneal dialysis treatment to remove waste and excess fluids from the body through the peritoneum. If treatment is halted prematurely while using this medication, it can pose a risk to life, so it must be used according to a physician's instructions. This medication should not be used in specific patient groups, such as those with a perforation of the diaphragm or severe burns or inflammation of the abdomen. Also, patients with severe electrolyte abnormalities, those recovering from abdominal surgery, and patients with serious lung diseases or sepsis may not be suitable for this medication. Special attention is needed for patients using digitalis preparations or those suspected of having metabolic disorders, as well as patients with lumbar disorders. During the dialysis process, abdominal pain, bleeding, peritonitis, electrolyte imbalance, and gastrointestinal symptoms may occur, so any unusual symptoms should be reported to medical personnel immediately. In peritoneal dialysis, procedures must be performed in a clean and sterile environment to prevent infections, and the patient's weight and electrolyte status should be periodically checked. Before use, it is essential to verify that the dialysis solution container is intact and not contaminated, and if the container is damaged or the contents are cloudy, it should not be used. Pregnant or breastfeeding women should use this medication cautiously under the physician's judgment, as its safety has not been established. Dosing adjustments and special precautions are needed for children and the elderly, and in cases of overdose, dehydration, electrolyte abnormalities, and hyperglycemia may occur, necessitating immediate action. This medication is intended solely for peritoneal dialysis and should not be used for any other purpose. When using, it should be warmed to body temperature in advance, and precautions should be taken to avoid direct sunlight and freezing during storage. During peritoneal dialysis, blood sugar, weight, nutritional status, and electrolyte concentrations should be regularly monitored to ensure appropriate treatment is provided.
Abdominal pain, bleeding, peritonitis, cloudy discharge, fever, inflammation around the abdominal catheter, erythema, secretion, catheter rupture, subcutaneous inflammation in the area of difficult drainage, nausea, abdominal colic, diarrhea, constipation, hemorrhoids, vomiting, loss of appetite, abdominal distension, intestinal obstruction, hypokalemia, hyponatremia, hypercalcemia, hypophosphatemia, hyperlactatemia, hypomagnesemia, hypercholesterolemia, hypertriglyceridemia, metabolic acidosis, hypoalbuminemia, hyperglycemia, respiratory distress due to diaphragm elevation, respiratory symptoms related to electrolyte disturbances, pulmonary edema, pleural effusion, edema, loss of amino acids or water-soluble vitamins, shoulder pain, muscle cramps, hernia, hydrocele, obesity, weakness, syncope, fatigue, headache, dizziness, tachycardia, hypertension, hypotension, sclerosing encapsulating peritonitis, sepsis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air contamination and kept in a cool place, below 25 degrees Celsius. Additionally, care should be taken to prevent the solution from freezing.
Clear and colorless liquid divided into two solutions: Solution A (left) and Solution B (right) in an A-shaped container.
Box of 1 pack (1,500 mL x 1, 2,000 mL x 1, 2,500 mL x 1, 3,000 mL x 1), Box of 4 packs (2,000 mL x 4, 2,500 mL x 4, 3,000 mL x 4), Box of 6 packs (1,500 mL x 6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Chloride 11.279g · Calcium Chloride Hydrate 0.5145g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 11.279g · Calcium Chloride Hydrate 0.5145g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 11.279g · Calcium Chloride Hydrate 0.5145g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 11.279g · Calcium Chloride Hydrate 0.3675g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 11.279g · Calcium Chloride Hydrate 0.3675g +3 more
Solution · Prescription medication · Combination
(Co., Ltd.) Fresenius Medical Care Korea
Sodium Chloride 11.279g · Calcium Chloride Hydrate 0.3675g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.